article thumbnail

Mapping the crisis: How data can help fix America’s growing pharmacy deserts

pharmaphorum

Skip to main content Thursday 12 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

article thumbnail

Grail plans FDA filing for cancer blood test after new trial

pharmaphorum

Skip to main content Friday 20 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

FDA 72
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Mastering Pharmaceutical Marketing: Strategies to Drive Success in the Pharma Industry

Pharma Marketing Network

Follow FDA guidelines on advertising to ensure your messaging is accurate and ethical. Develop blogs, white papers, and videos that educate and engage. Follow FDA guidelines, ensure accurate messaging, and work closely with legal and regulatory teams to review campaigns. Disclaimer: This content is not medical advice.

FDA 52
article thumbnail

FDA approves Sanofi and Regeneron’s Dupixent for bullous pemphigoid

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has approved Sanofi and Regeneron’s Dupixent (dupilumab) as a treatment option for adults with bullous pemphigoid (BP), a condition that predominantly affects the elderly. In February 2025, the FDA accepted Dupixent’s supplemental biologics licence application (sBLA) for priority review.

FDA 52
article thumbnail

Is Pay-Per-Click Advertising Working in Pharma?

Pharma Marketing Network

For example, tracking a user’s journey from a search ad to a white paper download offers valuable insight into funnel behavior. These formats not only engage users but also comply with FDA guidance when properly developed. These are ideal for promoting CME courses, white papers, and clinical trial updates.

FDA 52
article thumbnail

Basics on Creating a Lead Generation Network in Pharma

Pharma Marketing Network

Regulatory Constraints HIPAA, GDPR, and FDA guidelines shape how leads are collected, stored, and contacted. Webinars, white papers, and CME resources are particularly effective. Use clear opt-ins, partner with HIPAA-compliant vendors, and consult regulatory affairs to ensure all outreach meets FDA and GDPR standards.

article thumbnail

HCP Targeting in Pharma Marketing

Pharma Marketing Network

Educational webinars, white papers, and digital reprints are performing well, especially when endorsed by credible experts. All messaging must also go through MLR (medical, legal, and regulatory) review to ensure it aligns with FDA guidelines. Content quality is also essential.

HIPAA 52